Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Alaska by Borough or Census Area

Prostate (Late Stage^), 2016-2020

All Races (includes Hispanic), Male, All Ages

Sorted by Count

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


Alaska6


US (SEER+NPCR)1


Anchorage Municipality6


Matanuska-Susitna Borough6


Kenai Peninsula Borough6


Fairbanks North Borough6


Aleutians East Borough6 Aleutians West Census Area6 Bethel Census Area6 Bristol Bay Borough6 Denali Borough6 Dillingham Census Area6 Haines Borough6 Hoonah-Angoon Census Area6 Juneau City and Borough6 Ketchikan Gateway Borough6 Kodiak Island Borough6 Kusilvak/Wade Hampton Census Area6 Lake and Peninsula Borough6 Nome Census Area6 North Slope Borough6 Northwest Arctic Borough6 Petersburg Census Area6 Prince of Wales-Hyder Census Area6 Sitka City and Borough6 Skagway Municipality6 Southeast Fairbanks Census Area6 Valdez-Cordova Census Area6 Wrangell Borough6 Yakutat City and Borough6 Yukon-Koyukuk Census Area6

Notes:
Created by statecancerprofiles.cancer.gov on 03/28/2024 2:17 pm.

Alaska Census Area Name Change: please note that Wade Hampton Census Area, AK (FIPS code=02270) was renamed effective July 1, 2015, and the new name is Kusilvak Census Area (FIPS Code=02158). This website will use Kusilvak/Wade Hampton until the next incidence/mortality data release.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.